Back to Investors
N-

NPIF - Maven Equity Finance

Government

NPIF - Maven Equity Finance is part of the Northern Powerhouse Investment Fund and is managed by Maven.

Portfolio

3

companies


Portfolio companies

Biorelate

Biorelate

Biorelate provides an artificial intelligence platform that curates biomedical data to support drug discovery.

YF

YR Free

YR Free provides secure technology for digitally recorded media via a video collaboration platform called eviid.

M

Membr

Cloud-based fitness software platform helping gym owners manage members and digital content.


Team

JR

James Rosthorn

Investment Manager


Recent investments

Series A
£6.5M

The financing round was backed by Maven Capital Partners, YFM Equity Partners, Triple Point Ventures, and regional funds to support US growth.

"Drug discovery is so exciting right now, as there are just so many incredible companies working on remarkable new therapeutics. Equally, we are at a time where there is a stupendous amount of untapped evidence, like cause-and-effect, sat dark and subsequently unused by these same companies. Our mission at Biorelate is to capture this untapped data and help them make sense of it. With this improved understanding we are empowering these companies to make better decisions and speed up the drug discovery process."
— Dan Jamieson, founder and CEO
Seed
£600K

NPIF - Maven Equity Finance led the funding round, with additional backing from the Future Fund, to support the company as it expands its customer reach.

"At the heart of the eviid platform sits our unique patented evidential technology as well as a robust system for handling video in enterprise contexts. It’s incredibly scalable, with applications in numerous sectors beyond the ones we are serving today. The pandemic has really put video on the map and businesses around the world have realised how much can be done remotely. We have a long-term solution for this – a secure and proven system for integrating video and images into business workflows."
— John Ridd, CEO